Position in BMY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,089,877
-$89,277 QoQ
Shares Held
36,270
+0.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#821
of 2,506 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sargent Investment Group, LLC holds $34,963,451 across 9 Drug Manufacturers - General names. BMY ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
46,728 | $11,758,633 | |
| 2 | JNJ |
Johnson & Johnson
|
33,156 | $8,420,629 | |
| 3 | LLY |
ELI LILLY & Co
|
5,913 | $7,092,230 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,863 | $3,323,395 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
36,270 | $2,089,877 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,842 | $1,369,778 | |
| 7 | AMGN |
Amgen Inc
|
1,276 | $462,065 | |
| 8 | PFE |
Pfizer Inc
|
9,550 | $229,964 |
All Filings in BMY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,089,877 | 36,270 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,179,154 | 35,930 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,668,579 | 30,934 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,158,528 | 25,688 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,064,577 | 22,998 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,203,820 | 19,738 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $998,623 | 17,656 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $479,578 | 9,269 | Shares | Sole | 2024-11-06 | |
| 2023-12-31 | $294,570 | 5,741 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $566,818 | 9,766 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $591,217 | 9,245 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $651,652 | 9,402 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $671,077 | 9,327 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $663,056 | 9,327 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $752,521 | 9,773 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $781,640 | 10,703 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $660,099 | 10,587 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $647,733 | 10,947 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $709,093 | 10,612 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $668,988 | 10,597 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $532,217 | 8,580 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $252,313 | 4,185 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||